Leaders in today’s global pharmacovigilance (PV) teams are being pulled in two directions. On one side: the relentless demands of regulatory compliance. On the other hand, the growing need to act fast, make smarter decisions, and elevate safety strategy. Aggregate reports sit right at the intersection of these pressures. And if you ask any seasoned PV expert, especially those driving innovation at EVERSANA, they’ll tell you: these reports are no longer just compliance documents. They’re intelligence assets. And it’s time we treated them as such.
Aggregate reporting has traditionally been one of the most resource-heavy areas in PV. Whether it’s PSURs, PADERs, or DSURs, the process often involves endless data reconciliation, siloed systems, version chaos, and a looming sense that one missed deadline could spiral into regulatory risk. And yet, buried within these reports is a goldmine of insights, if only we had the time to extract them.
Our Solution: ORCHESTRATE PV and the Shift to Strategic Safety
At EVERSANA, Simplifying PV isn’t about removing rigor, it’s about removing friction. Our pharmacovigilance and medical safety teams have spent years in the trenches—filing global reports under pressure, managing inspections, and navigating the chaos of mismatched formats and shifting timelines. So when we built ORCHESTRATE PV, we didn’t just build automation. We embedded the experience of every PV lead who’s ever said, “There has to be a better way.”
Let’s start with what’s broken. Aggregate reports are still treated by many as static outputs: collected, compiled, submitted, and shelved. But that view is outdated. Every report is an opportunity to surface patterns:
- Are we seeing an uptick in hepatotoxicity reports across regions?
- Are reporting rates shifting post-label change?
- What are our evolving benefit-risk dynamics in older populations?
That’s the level of inquiry PV needs to operate at. And that’s what ORCHESTRATE PV is engineered to deliver.
Key Benefits: Efficiency, Accuracy, and Cost Savings
The platform takes the noise out of the process. It auto-ingests safety data from systems like Argus and literature platforms. It streamlines workflows with built-in templates, role assignments, and scheduling that mirrors global regulatory calendars. We’re not talking about marginal time savings—we’re talking about producing audit-ready PADERs in three clicks, with over 99% accuracy: no rework, no formatting firefights, and no last-minute scrambling.
Safety teams can now focus on interpretation. What is the report telling us? What risks are emerging? What mitigation is needed?
There’s a mindset shift baked into this. Simplifying PV isn’t about pushing buttons faster. It’s about giving PV leaders the space to lead. We’re helping them move from operational firefighting to strategic orchestration. The platform’s audit trails ensure full traceability and oversight throughout the reporting process. When global teams can see every report’s status, risk flags, and data flow in one place, it’s a position of clarity, and a great place to be.
And yes, the results speak volumes. We’ve seen up to 40% cost savings in aggregate reporting workflows, with timelines cut in half and narrative authoring reduced from days to hours.
Results That Matter: Proven Impact on PV Operations
Partnering with EVERSANA means embedding that shift into your operations. You’re not just licensing software, you’re aligning with PV practitioners, regulatory experts, and AI engineers who understand where the bottlenecks are and how to remove them. You’re getting a platform that evolves with regulatory demands, scales across portfolios, and integrates into the systems you already use.
So here’s the call: stop viewing aggregate reports purely as compliance hurdles. Start treating them as strategic tools. When you simplify PV, not by cutting corners but by eliminating inefficiencies, you unlock the real potential of your safety data.
And with EVERSANA ORCHESTRATE PV, you don’t have to do it alone. We’ve been where you are. Let’s take the next step in advancing pharmacovigilance together.